RSSCategory: Advocacy

PathVision Helping Pathology

| June 28, 2017 | 0 Comments

Faxitron has released a new video highlighting their PathVision in use at Allina Health in Minneapolis. The video discusses how direct imaging of breast pathology specimens in the gross room facilitate coordinated care with radiology and surgery colleagues to identify mass lesions, surgical clips, localization wires and radioactive seeds. This multi-disciplinary approach with real-time specimen […]

Continue Reading

Huron Digital Pathology Breaks Ground on New R&D and Manufacturing Facility

| June 27, 2017 | 0 Comments

As I mentioned in a post earlier this year following a visit to the existing Huron Digital Pathology headquarters in Ontario, Canada, St. Jacobs can now lay claim to not only the best apple fritters in the world but the new home of Huron Digital Pathology! There are a lot of interesting facets to the […]

Continue Reading

Q&A with Philips Digital Pathology

| June 23, 2017 | 0 Comments

I recently had an opportunity to speak with Esther Abels, Director of Regulatory, Clinical and Medical Affairs for Philips Digital Pathology Solutions about Philips’ recent approval to market their Philips Intellisite Pathology System (PIPS) for primary diagnosis of biopsies and excisions in the United States. My thanks to Esther and Philips’ marketing team for their […]

Continue Reading

PathPresenter.com – An Innovative Platform For Digital Pathology

| June 20, 2017 | 0 Comments

Let me describe a common scenario that plays out every week in a pathology department: You want to teach students, residents, or fellows a particular topic. You spend hours searching for cases and find some (but not enough) for a good teaching session. You know the department has a huge collection of great cases hiding […]

Continue Reading

Tomorrow’s Webinar from Philips: Unlocking the Full Potential of Digital Pathology

| June 12, 2017 | 0 Comments

Tuesday, June 13th, Philips Digital Pathology Solutions will host two webinars for: North America: 10:00 AM – 11:00 AM EDT Register Asia & Europe: 3:00 PM – 4:00 PM SGT Register Philips IntelliSite Pathology Solution is now available for primary diagnostic use in the USA; but what does this news mean for the field of pathology? In […]

Continue Reading

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

Webinar: Unlocking the Full Potential of Digital Pathology

| May 31, 2017 | 0 Comments

Tuesday, June 13th, Philips Digital Pathology Solutions will host two webinars for: North America: 10:00 AM – 11:00 AM EDT Register Asia & Europe: 3:00 PM – 4:00 PM SGT Register Philips IntelliSite Pathology Solution is now available for primary diagnostic use in the USA; but what does this news mean for the field of […]

Continue Reading

“Digital Pathology Stands to Reduce Cancer Misdiagnoses”

| May 21, 2017 | 0 Comments

With the ink dry about a month on the recent FDA approval of Philips Intellisite Pathology Solution (PIPS) for primary diagnosis, I came across this headline and others like it last week. Well known, respected pathologists and pathology informaticians at well-known cancer centers provided quotes for the articles. When you contribute to an article, you […]

Continue Reading

Webinar: Panoptiq Use Cases in Pathology

| May 16, 2017 | 1 Comment

Matthew G Hanna, M.D., Clinical Instructor of Pathology Informatics, University of Pittsburgh Wed, May 17th, 2017 2:00PM EST Join Dr. Matthew Hanna, MD, Pathologist and Clinical Instructor of Pathology Informatics at the University of Pittsburgh, as he discusses multiple use cases for Panoptiq. Panoptiq takes a software-based approach to digital imaging, and as such integrates […]

Continue Reading

What does FDA Approval Mean for the Digital Pathology Market? Part 1

| May 15, 2017 | 0 Comments

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary surgical pathology diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA approved whole slide imaging system for primary diagnosis. For groups and hospitals that appreciate the two main […]

Continue Reading

ASI’s HiPath™ For Computer-Assisted PD-L1 Interpretation

| May 12, 2017 | 0 Comments

HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 — Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1 assays. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in […]

Continue Reading

Leica Biosystems Applauds FDA Primary Diagnosis Clearance as a Step Forward in Clinical Acceptance of Digital Pathology

| May 11, 2017 | 0 Comments

VISTA, CA – May 11, 2017 – The digital pathology industry just took another step forward, with the FDA clearance of a whole slide imaging (WSI) system (Philips IntelliSite™ Pathology Solution) for review of digital surgical pathology slides. Leica Biosystems congratulates both the FDA and the Digital Pathology Association (DPA) on this positive outcome from […]

Continue Reading

Guest Post: AI vs MD – What it Means for Pathology

AI vs MD: What it means for Pathology By David West, CEO, Proscia Will computers replace doctors? It’s the question on everyone’s mind when reading Siddhartha Mukherjee’s article in the New Yorker “AI vs MD”, which pits human doctors against computers. It’s a beautifully composed summary on the role of software algorithms in healthcare, examining […]

Continue Reading

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology

Hørsholm, Denmark, May 3rd – Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep Learning an important technological breakthrough for tissue pathology that offers the potential to make a real difference in the assessment of […]

Continue Reading